Valuation (97%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 8.79 | N/A |
| PEG Ratio (TTM) | 0.77 | N/A |
| P/S Ratio (TTM) | 1.15 | N/A |
| P/B Ratio (TTM) | 0.76 | N/A |
| P/FCF Ratio (TTM) | 0.75 | N/A |
| Price to 5YR AVG Earnings Ratio | 1.00 | N/A |
| Price to 5YR AVG FCF Ratio | 3.09 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.72% | N/A |
| ROE (TTM) | 8.76% | N/A |
| Net Profit Margin (TTM) | 14.34% | N/A |
| ROIC 5YR AVG | 8.88% | N/A |
Growth (62%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 36.72% | 16.19% | 1.36% |
| Revenue | 0.90% | 6.38% | 3.45% |
| Net Income | 36.89% | 16.14% | 1.43% |
| Cash Flow | -10.53% | 153.71% | 100.33% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.44 | N/A |
| Quick Ratio (TTM) | 2.44 | N/A |
| D/E Ratio (TTM) | 2.32 | N/A |
| Interest Coverage (TTM) | 0.20 | N/A |
| Piotroski F-Score | 4 | N/A |
| Altman Z-Score | 0.56 | N/A |
| LTL to 5YR AVG FCF | 51.65 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.09% | N/A |